Patients with type 1 diabetes bear the risk of problematic hypoglycemia. The current treatment of hypoglycemia induced unconsciousness is intramuscular glucagon. A new study reveals intranasal glucagon spray can be an excellent alternative, especially in the cases where intramuscular glucagon administration may be difficult. Hypoglycemia is a major barrier to the attainment of glycemic control targets in diabetic patients. Quite often hypoglycemia occurs outside hospital settings.
In severe cases, patients may lose their consciousness. The gold-standard treatment for such cases is intramuscular glucagon injection. However, the process of injection of intramuscular glucagon is error prone in an emergency. The scientists from the USA has found a new way of administration of glucagon in severe hypoglycemic patients. The scientists conducted a multicenter randomized crossover…
